Enveric Biosciences Inc vs Intuitive Surgical, Inc. — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Intuitive Surgical, Inc. trades at $400.41 (market cap $137.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 25894.7× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ENVB | ISRG | |
|---|---|---|
Market Cap | $5.32M | $137.76B |
Sector | Health | Health |
52-Week High | $17.40 | $592.85 |
52-Week Low | $1.28 | $379.50 |
Enterprise Value | $408.82K | $133.24B |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →